Galderma stock faces CFO transition ahead of December board vote
Published on 11/10/2026 at 11:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGovernance changes set next steps
- Galderma said CFO Luigi La Corte will leave the company while supporting a transition.
- Shareholders will vote on two proposed directors and board changes at a virtual meeting on December 3, 2026.
- The proposals are intended to strengthen governance as Galderma pursues its long-term growth strategy.
Galderma announced on November 2, 2026, that Chief Financial Officer Luigi La Corte will leave the dermatology company to pursue a significant new opportunity. The announcement, published by Business Wire, said La Corte will continue in his role during the transition to support business continuity and a smooth handover.
Board proposals go to shareholders
Galderma proposed Rosalind Brewer and Petra Rumpf as new members of the Board of Directors. The company said both candidates bring leadership and governance experience across consumer businesses, healthcare, medical technology and life sciences.
The board also proposed increasing its maximum size from 10 to 11 members. Sherilyn McCoy is expected to step down after seven years because of conflicting obligations, while the company is seeking shareholder approval for Brewer and Rumpf to serve until the next Annual General Meeting.
Brewer is additionally proposed for individual election to the Compensation Committee. Galderma's chief executive, Flemming Ornskov, said the appointments would add expertise and perspectives as the group executes its Integrated Dermatology Strategy and pursues its long-term ambitions.
December vote is the next milestone
The extraordinary general meeting will take place virtually on Thursday, December 3, 2026, at 14:00 CET. Investors will therefore have to assess the CFO succession alongside the proposed board expansion and committee appointment rather than as an isolated personnel change.
Galderma stock traded at 203.00 euros on Lang & Schwarz at 11:49 CET on Tuesday, November 10, 2026.
Galderma Group AG
- Company: Galderma Group AG
- ISIN: CH1335392721
- Home exchange: SIX Swiss Exchange
- Lang & Schwarz quote: 203.00 euros at 11:49 CET on November 10, 2026
- Upcoming event: Extraordinary General Meeting on December 3, 2026, at 14:00 CET
The Swiss SMI market provides the broader home-market context for Galderma's governance changes.
